Results 21 to 30 of about 104,235 (402)

Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

open access: yesМедицинский совет, 2022
Introduction. Gastroesophageal reflux disease (GERD) is extremely common in the structure of gastroenterological diseases. Aim. To conduct a prospective observational post-marketing study of rabeprazole (Razo®) 20 mg taking once daily in patients with ...
V. V. Tsukanov   +6 more
doaj   +1 more source

Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor–Related Esophagitis

open access: yesThe Journal of the National Comprehensive Cancer Network, 2021
Background: Although immune checkpoint inhibitors (ICIs) have provided practice-changing outcomes in treating many cancers, ICI-related gastrointestinal toxicity can limit their use.
Kavea Panneerselvam   +11 more
semanticscholar   +1 more source

Eosinophilic esophagitis and esophageal microbiota

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
Eosinophilic esophagitis (EoE) is an antigen-mediated chronic inflammatory disease of the esophagus, the prevalence of which has steadily increased in recent years. The pathogenesis of EoE is not yet well-defined; however, recent studies have demonstrated that the esophageal microbiota is an essential regulator of physiological and pathological ...
Xiaohan Zhang   +4 more
openaire   +3 more sources

H influenzae LPS colocalization with Toll-like receptor 4 in eosinophilic esophagitis

open access: yesJournal of Allergy and Clinical Immunology: Global, 2023
Background: Patients with eosinophilic esophagitis (EoE) have a unique esophageal microbiome with increased presence of Haemophilus influenzae, but its role in the disease is unclear.
Anupama Ravi, MD   +4 more
doaj   +1 more source

Steroids in pediatric eosinophilic esophagitis [PDF]

open access: yes, 2014
Swallowed fluticasone and oral viscous budesonide are effective first-line therapies for eosinophilic esophagitis in children. Side effects are minimal without evidence of Cushing syndrome, as seen in treatment with systemic corticosteroids.
Contreras, Emily M., Gupta, Sandeep K.
core   +1 more source

MAST CELLS DISTINGUISH EOSINOPHILIC ESOPHAGITIS IN PEDIATRIC PATIENTS

open access: yesArquivos de Gastroenterologia, 2017
BACKGROUND: Mast cells exert a substantial role in gastrointestinal allergic diseases. Therefore, it is reasonable to presume that mast cell may aid diagnosis in eosinophilic gastroenteropathy.
Elizete Aparecida LOMAZI   +4 more
doaj   +1 more source

Corrosive Esophagitis and Gastritis Induced by Glutaraldehyde Ingestion [PDF]

open access: yesThe Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2020
Corrosive esophagitis and gastritis are characterized by caustic damage due to ingestion of chemical agents. Caustic agents cause tissue destruction through liquefaction or coagulation reactions.
Donghwan Jun   +6 more
doaj   +1 more source

Emerging therapies for eosinophilic esophagitis

open access: greenJournal of Allergy and Clinical Immunology, 2019
Thomas Greuter   +2 more
openalex   +2 more sources

Development and Application of a Functional Human Esophageal Mucosa Explant Platform to Eosinophilic Esophagitis. [PDF]

open access: yes, 2019
There is an increasing prevalence of esophageal diseases but intact human tissue platforms to study esophageal function, disease mechanisms, and the interactions between cell types in situ are lacking.
Aceves, Seema S   +12 more
core   +3 more sources

Home - About - Disclaimer - Privacy